Physician profile
Yi Guo
NPI 1760893283
$12,871.72
in general payments reported to CMS, 2019-2025
12 companies · $2,707 in 2025
The $2,707 reported for 2025 was more than what 75% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $748 · 2020: $455 · 2021: $2,577 · 2022: $2,498 · 2023: $930 · 2024: $2,957 · 2025: $2,707.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,504 · Travel and Lodging: $2,090.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,504.20 |
| Travel and Lodging | $2,089.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,718.21 | 2019-2025 | Infinity, Augment Injectable, Inbone |
| Gotham Surgical Solutions & Devices, INC. | $4,696.77 | 2020-2025 | |
| Arthrex, INC. | $1,731.15 | 2024-2025 | |
| Medtronic USA, INC. | $484.39 | 2019 | |
| Zimmer Biomet Holdings, INC. | $382.66 | 2022-2025 | Comprehensive Shoulder System, Tapestry |
| Depuy Synthes Sales INC. | $238.69 | 2025 | Na, Va-Lcp |
| Kedrion Biopharma, INC. | $149.80 | 2024 | Kedrab, Gammaked, Koate |
| Genzyme Corporation | $142.48 | 2025 | |
| Kerecis Limited | $141.93 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Acell, INC. | $119.43 | 2019 | |
| Bioventus LLC | $36.34 | 2023 | Exogen Ultrasound Bone Healing System |
| Merck Sharp & Dohme LLC | $29.87 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yi Guo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.